The U.S. Army has awarded FLIR Systems a $21.8 million contract to deliver its Agentase C2 spray to detect G- and V-series nerve agents, which are highly toxic chemical warfare agents.
It is a full-rate production option worth $21.8 million on an indefinite-delivery/ indefinite-quantity (IDIQ) contract. It supports the Army’s Contamination Indicator/Decontamination Assurance System (CIDAS) program, which is the “program of record’ within the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND).
FLIR Agentase C2 spray quickly changes color on a surface if a chemical warfare agent is detected. With faster and more targeted detection, military decontamination experts can locate trace levels of contamination to better mitigate the threat.
“Nerve agents such as VX and sarin are of vital concern to the U.S. military,” FLIR Vice President and General Manager of Sensor Systems Tim Durham said. “Our Agentase C2 spray technology enables rapid detection of highly toxic substances while reducing the lifecycle cost of decontamination operations. FLIR is proud to continue its important work with the Army delivering solutions that help safeguard our warfighters.”
The original IDIQ contract was awarded in 2015 and consisted of an engineering and manufacturing development phase, followed by a low-rate initial production phase. This latest award is for a full-rate production phase through 2025. Shipments are scheduled to start in the fourth quarter of 2020.
In September 2019, FLIR won a $35.1 million contract with the U.S. Army to deliver its disclosure spray formulated for blister agents such as sulfur mustard.